| Medicare WPS | Billing and Coding: MolDX: Decision Dx-UM (Uveal Melanoma) (57566) | 2024-06-18 |
| Medicare WPS | Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (58205) | 2024-06-18 |
| Medicare WPS | Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (58473) | 2024-06-18 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Treatment of Abnormal Uterine Bleeding and Uterine Fibroids | 2024-06-17 |
| BCBS Highmark Penn Medicare Advantage | Ziv-aflibercept (Zaltrap) | 2024-06-17 |
| BCBS Highmark Penn Medicare Advantage | Talimogene Laherparepvec (Imlygic) | 2024-06-17 |
| BCBS Highmark Penn Medicare Advantage | Injectable Collagenase Clostridium Histolyticum (Xiaflex) | 2024-06-17 |
| BCBS Highmark Delaware | Treatment of Abnormal Uterine Bleeding and Uterine Fibroids | 2024-06-17 |
| BCBS Highmark West Virginia | Treatment of Abnormal Uterine Bleeding and Uterine Fibroids | 2024-06-17 |
| BCBS Texas Medical Policies | Allergy Management | 2024-06-15 |